Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingre Shuji Fang (清热舒脊方) is a traditional Chinese medicine (TCM) formula used in the management of ankylosing spondylitis and potentially other inflammatory musculoskeletal conditions. The name translates to "Heat-Clearing and Spine-Soothing Formula." It is typically administered as part of an integrative approach, often combined with standard Western medical treatments. The formula's mechanism of action is based on TCM principles—primarily clearing heat, dispelling dampness, promoting blood circulation, and relieving pain. Its precise herbal composition may vary but generally includes herbs with anti-inflammatory and immunomodulatory properties according to TCM theory[1]. Clinical studies have been conducted to evaluate its efficacy and safety in ankylosing spondylitis patients[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingre Shuji Fang.